Table 1.
Diagnosis and screening.
| January | February | March | April | May | June | July | August | September | October | November | December | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Digestive tract endoscopies | |||||||||||||
| 2019 | 308,959 | 286,816 | 308,816 | 304,647 | 298,963 | 289,361 | 284,372 | 170,407 | 290,696 | 318,586 | 282,356 | 253,945 | 3,397,924 |
| 2020 | 308,279 | 281,211 | 174,032 | 53,294 | 141,927 | 262,496 | 270,006 | 175,477 | 294,410 | 289,393 | 254,132 | 244,734 | 2,749,391 |
| 2021 | 279,495 | 263,955 | 286,928 | 830,378 | |||||||||
| Difference 2019/2020 | − 680 | − 5605 | − 134,784 | − 251,353 | − 157,036 | − 26,865 | − 14,366 | 5070 | 3714 | − 29,193 | − 28,224 | − 9211 | − 648,533 |
| Percent 2019/2020 | − 0.2 | − 2.0 | − 43.6 | − 82.5 | − 52.5 | − 9.3 | − 5.1 | 3.0 | 1.3 | − 9.2 | − 10.0 | − 3.6 | − 19.1 |
| Difference 2019/2021 | − 29,464 | − 22,861 | − 21,888 | − 74,213 | |||||||||
| Percent 2019 − 2021 | − 9.5 | − 8.0 | − 7.1 | ||||||||||
| Bronchial and ENT endoscopies | |||||||||||||
| 2019 | 107,085 | 95,901 | 106,923 | 103,516 | 101,351 | 96,611 | 98,820 | 66,621 | 99,083 | 106,101 | 95,484 | 88,893 | 1,166,389 |
| 2020 | 104,733 | 97,579 | 64,651 | 28,750 | 60,831 | 92,028 | 85,333 | 60,821 | 93,928 | 87,278 | 85,568 | 81,283 | 942,783 |
| 2021 | 87,914 | 82,669 | 94,018 | 264,601 | |||||||||
| Difference 2019/2020 | − 2352 | 1678 | − 42,272 | − 74,766 | − 40,520 | − 4583 | − 13,487 | − 5800 | − 5155 | − 18,823 | − 9916 | − 7610 | − 223,606 |
| Percent 2019/2020 | − 2.2 | 1.7 | − 39.5 | − 72.2 | − 40.0 | − 4.7 | − 13.6 | − 8.7 | − 5.2 | − 17.7 | − 10.4 | − 8.6 | − 19.2 |
| Difference 2019/2021 | − 19,171 | − 13,232 | − 12,905 | − 45,308 | |||||||||
| Percent 2019–2021 | − 17.9 | − 13.8 | − 12.1 | ||||||||||
| Mammograms | |||||||||||||
| 2019 | 473,347 | 421,823 | 461,522 | 445,034 | 442,258 | 423,883 | 404,342 | 284,033 | 449,133 | 494,668 | 445,629 | 386,486 | 5,132,158 |
| 2020 | 478,150 | 437,774 | 254,122 | 66,597 | 278,076 | 455,482 | 406,343 | 316,109 | 504,807 | 508,138 | 495,773 | 438,251 | 4,639,622 |
| 2021 | 474,674 | 445,114 | 523,430 | 1,443,218 | |||||||||
| Difference 2019/2020 | 4803 | 15,951 | − 207,400 | − 378,437 | − 164,182 | 31,599 | 2001 | 32,076 | 55,674 | 13,470 | 50,144 | 51,765 | − 492,536 |
| Percent 2019/2020 | 1.0 | 3.8 | − 44.9 | − 85.0 | − 37.1 | 7.5 | 0.5 | 11.3 | 12.4 | 2.7 | 11.3 | 13.4 | − 9.6 |
| Difference 2019/2021 | 1327 | 23,291 | 61,908 | 86,526 | |||||||||
| Percent 2019 − 2021 | 0.3 | 5.5 | 13.4 | ||||||||||
| Colorectal screening | |||||||||||||
| 2019 | 212,938 | 199,831 | 200,709 | 160,751 | 116,359 | 92,929 | 72,041 | 68,759 | 139,420 | 225,007 | 273,084 | 240,014 | 2,001,842 |
| 2020 | 293,675 | 310,605 | 206,161 | 12,976 | 68,865 | 169,754 | 212,947 | 215,809 | 325,936 | 353,617 | 324,902 | 305,949 | 2,801,196 |
| 2021 | 288,421 | 276,819 | 406,604 | 971,844 | |||||||||
| Difference 2019/2020 | 80,737 | 110,774 | 5452 | − 147,775 | − 47,494 | 76,825 | 140,906 | 147,050 | 186,516 | 128,610 | 51,818 | 65,935 | 799,354 |
| Percent 2019/2020 | 37.9 | 55.4 | 2.7 | − 91.9 | − 40.8 | 82.7 | 195.6 | 213.9 | 133.8 | 57.2 | 19.0 | 27.5 | 39.9 |
| Difference 2019/2021 | 75,483 | 76,988 | 205,895 | 358,366 | |||||||||
| Percent 2019 − 2021 | 35.4 | 38.5 | 102.6 | ||||||||||
| Cervix screening (HPV and cytopathology) | |||||||||||||
| 2019 | 411,678 | 378,100 | 416,419 | 399,230 | 397,281 | 377,125 | 370,493 | 242,953 | 398,372 | 424,446 | 369,701 | 337,462 | 4,523,260 |
| 2020 | 410,798 | 377,973 | 252,407 | 80,142 | 260,984 | 433,787 | 366,413 | 259,785 | 430,692 | 414,737 | 393,093 | 342,051 | 4,022,862 |
| 2021 | 369,688 | 342,946 | 360,992 | 1,073,626 | |||||||||
| Difference 2019/2020 | − 880 | − 127 | − 164,012 | − 319,088 | − 136,297 | 56,662 | − 4080 | 16,832 | 32,320 | − 9709 | 23,392 | 4589 | − 500,398 |
| Percent 2019/2020 | − 0.2 | 0.0 | − 39.4 | − 79.9 | − 34.3 | 15.0 | − 1.1 | 6.9 | 8.1 | − 2.3 | 6.3 | 1.4 | − 11.1 |
| Difference 2019/2021 | − 41,990 | − 35,154 | − 55,427 | − 132,571 | |||||||||
| Percent 2019 − 2021 | − 10.2 | − 9.3 | − 13.3 | ||||||||||
| Prostatic biopsies | |||||||||||||
| 2019 | 9562 | 8447 | 9075 | 8810 | 8675 | 8247 | 7826 | 5120 | 9099 | 9004 | 8102 | 6853 | 98,820 |
| 2020 | 10,151 | 8560 | 6217 | 2975 | 6601 | 9176 | 7549 | 5042 | 9201 | 8621 | 8673 | 7451 | 90,217 |
| 2021 | 9390 | 8251 | 8989 | 26,630 | |||||||||
| Difference 2019/2020 | 589 | 113 | − 2858 | − 5835 | − 2074 | 929 | − 277 | − 78 | 102 | − 383 | 571 | 598 | − 8603 |
| Percent 2019/2020 | 6.2 | 1.3 | − 31.5 | − 66.2 | − 23.9 | 11.3 | − 3.5 | − 1.5 | 1.1 | − 4.3 | 7.0 | 8.7 | − 8.7 |
| Difference 2019/2021 | − 172 | − 196 | − 86 | − 454 | |||||||||
| Percent 2019 − 2021 | − 1.8 | − 2.3 | − 0.9 | ||||||||||
Number of screening and diagnostic acts observed are in [bold].
HPV human papilloma viridae.